Treatment of Borderline Personality Disorder
Dialectical Behavior Therapy (DBT) is the first-line treatment for borderline personality disorder, as it is the only psychotherapy proven in randomized controlled trials to reduce suicidality and is recommended by the American Academy of Child and Adolescent Psychiatry as the most effective psychiatric treatment for this population. 1, 2
Psychotherapy: The Primary Treatment Modality
DBT as First-Line Treatment
Initiate DBT immediately for any patient with borderline personality disorder who has recent self-harm, suicide attempts, or chronic suicidal ideation. 1 DBT directly addresses suicidal behavior by teaching distress-tolerance and emotion-regulation skills as alternatives to maladaptive coping with painful negative emotions. 1
Standard DBT consists of weekly individual therapy plus weekly group skills training over a one-year period, covering four core modules: mindfulness, emotion regulation, distress tolerance, and interpersonal effectiveness. 1, 2 This comprehensive structure is non-negotiable for optimal outcomes. 1
Evidence Supporting DBT Superiority
Multiple systematic reviews demonstrate that DBT reduces both suicidal and non-suicidal self-directed violence among patients with borderline personality disorder, with moderate to large statistically significant effects over treatment as usual. 2 DBT shows superiority over client-centered therapy for treating both core borderline personality pathology and associated symptoms, and has demonstrated efficacy in reducing anger, parasuicidal behavior, and improving mental health. 2
While other psychotherapies (schema therapy, transference-focused psychotherapy, acceptance and commitment therapy, manual-assisted cognitive therapy, cognitive behavioral therapy) show effectiveness compared to treatment as usual, the evidence base for DBT is most robust. 3, 4
Special Considerations for Adolescents
For teenagers (approximately 14-18 years) displaying borderline personality traits, suicidal behaviors, or severe emotional dysregulation, use DBT-A (DBT adapted for adolescents). 1 DBT-A is organized into two 12-week stages using simplified language appropriate for adolescents. 1
DBT-A mandates family participation in skills-training groups to improve the home environment, with family members tasked with modeling and reinforcing adaptive behaviors. 1, 2 DBT-A reduces psychiatric hospitalization rates among suicidal adolescents with borderline features—approximately 83% of DBT-treated youths show decreased suicidal ideation versus 50% of standard-care peers who show increased ideation. 1
Pharmacotherapy: Adjunctive Role Only
Core Principle
Psychotherapy is the treatment of choice; no medication consistently improves core borderline personality features, and medications should only target specific comorbid conditions or acute crises. 1 The prescription of medications should be considered only as an adjunct to BPD-specific psychotherapy. 5
When to Use Medications
For comorbid major depression, use selective serotonin reuptake inhibitors (SSRIs) as preferred agents due to their better safety profile in overdose. 6, 5 SSRIs have been shown to reduce suicidal ideation and suicide attempts in adults with cluster-B personality disorders. 6
When starting SSRIs, monitor closely for emergence of new suicidal thoughts or akathisia, especially during the first weeks of treatment. 6
Critical Medications to Avoid
Avoid tricyclic antidepressants due to their high lethality in overdose—the therapeutic dose is close to the toxic dose, making overdose potentially lethal, and they have not demonstrated efficacy for treating depression in borderline personality disorder. 6, 5
Avoid benzodiazepines as they may increase disinhibition and impulsivity in patients with borderline personality disorder. 1, 6 If they must be prescribed, it should be done with extreme caution and only when absolutely necessary. 6
Medication Management Safeguards
All psychotropic medications must be overseen by a designated third party; any change in patient behavior or emergence of side effects should be reported immediately to the treatment team. 6 Securing all prescribed medications and arranging third-party monitoring of medication access significantly reduces suicidal behavior in patients with borderline personality disorder. 6
Polypharmacy and the use of unsafe drugs (i.e., with a risk of overdose) should be avoided. 5
Safety Planning: Non-Negotiable Component
Develop a collaborative safety plan immediately—this is non-negotiable and evidence-based for reducing suicidal behavior, with a number needed to treat (NNT) of 16. 6
The safety plan must include specific, actionable components: warning signs identification, internal coping strategies, and social contacts for distraction. 6 Restricting access to lethal means, including removing firearms from the home and locking up medications, is a critical component of safety planning. 6
"No-suicide" contracts have no proven efficacy and should not replace active safety-planning measures; reliance on such contracts may lead to reduced vigilance. 6
Ongoing Monitoring Requirements
Schedule definite, closely spaced follow-up appointments and contact the patient if appointments are missed—this is not optional. 6 Treating clinicians should ensure continuous availability to patients and families outside regular therapeutic hours, or arrange adequate physician coverage, to promptly address emergent safety concerns. 6
Sending periodic caring communications, such as postal mail or text messages, for 12 months following any hospitalization or crisis can reduce suicide attempts. 6
Assessment Before Treatment Initiation
Conduct a thorough evaluation focusing on suicide risk assessment, family psychiatric history, comorbid conditions, and childhood trauma history before initiating treatment. 1 Screen for depression, anxiety disorders, substance use disorders, and bipolar disorder, as they are common comorbidities. 1
Confirm the patient's ability to establish a therapeutic alliance and reliably inform the therapist about suicidal preoccupations. 1 DBT was developed for non-psychotic patients; acute psychotic symptoms must be stabilized before DBT initiation. 1
Common Pitfalls to Avoid
Do not rely solely on pharmacotherapy. The evidence consistently shows psychotherapy is primary, with medications playing only an adjunctive role for specific comorbidities. 1, 5
Do not use suicide-risk stratification tools as the sole determinant of risk. Current evidence is insufficient to support the routine use of specific suicide-risk stratification tools for determining level of risk in borderline personality disorder. 6
Do not implement DBT without the full structure. Standard DBT requires both individual therapy and group skills training—partial implementation reduces effectiveness. 1, 2
Do not exclude family members from adolescent treatment. Family participation in DBT-A is mandatory for optimal outcomes. 1, 2